5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor

Citation
Mp. Blanton et al., 5-Hydroxytryptamine interaction with the nicotinic acetylcholine receptor, EUR J PHARM, 389(2-3), 2000, pp. 155-163
Citations number
34
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
389
Issue
2-3
Year of publication
2000
Pages
155 - 163
Database
ISI
SICI code
0014-2999(20000218)389:2-3<155:5IWTNA>2.0.ZU;2-J
Abstract
The present study examines the interaction of the neurotransmitter 5-hydrox ytryptamine (5-HT) with muscle-type nicotinic acetylcholine receptors. 5-HT inhibits the initial rate of [I-125]alpha-bungarotoxin binding to Torpedo acetylcholine receptor membranes (IC50 = 8.5 +/- 0.32 mM) and [H-3]5-HT can be photoincorporated into acetylcholine receptor subunits, with labeling o f the alpha-subunit inhibitable by both agonists and competitive antagonist s. Within the agonist-binding domain, [H-3]5-HT photoincorporates into alph a Tyr(190), alpha Cys(192) and alpha Cys(193). Functional studies using the human clonal cell line TE671/RD, show that 5-HT is a weak inhibitor (IC50 = 1.55 +/- 0.25 mM) of acetylcholine receptor activity. In this regard, ago nist-response profiles in the absence and presence of 5-HT indicate a nonco mpetitive mode of inhibition. In addition, 5-HT displaces high affinity [H- 3]thienylcyclohexylpiperidine binding to the desensitized Torpedo acetylcho line receptor channel (IC50 = 1.61 +/- 0.07 mM). Collectively, these result s indicate that 5-HT interacts weakly with the agonist recognition site and inhibits receptor function noncompetitively by binding to the acetylcholin e receptor channel. (C) 2000 Elsevier Science B.V. All rights reserved.